Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
SCM Lifescience Co., LTD.
Age
19–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects who are males or females aged \>= 19 years, 40kg to 80kg in weight
Steroid dependent/refractory chronic graft versus host disease (cGVHD) defined as the National Institutes of Health (NIH) criteria (2014) below at any time post-hematopoietic cell transplant (post-HCT):
Refractory disease, defined as, 1) when cGVHD manifestations progress despite the use of a regimen containing glucocorticoid (prednisolone at \>=1 mg/kg/day for at least 2 weeks) or 2), 3) Persist without improvement despite continued treatment with glucocorticoid (prednisolone at \>=0.5 mg/kg/day or 1 mg/kg every other day) for at least 4 weeks Dependent disease, defined as, 4), 5) when glucocorticoid (prednisolone doses greater than or equal to \[\>=\] 0.25 milligram per kilogram per day (mg/kg/day)or \>=0.5 milligram per kilogram (mg/kg) every other day) are needed to prevent recurrence or progression of manifestations as demonstrated by unsuccessful attempts to taper the dose to lower levels on at least 2 occasions, separated by at least 8 weeks.
Participants must be receiving less than 3 systemic glucocorticoid therapies or other immunosuppressive therapies in addition to glucocorticoids for cGVHD for at least 4 weeks before Screening visit. The dose of steroids or Immunosuppressant must be stable for 14 days(2 weeks) prior to starting SCM-CGH or Placebo.
Laboratory test sufficiency as follows; Absolute neutrophil count (ANC) ≥ 1,000 cells/mm3 Serum creatinine \< 2 x upper limit of normal (ULN)
You may not be if
Active acute graft versus host disease (GVHD)
Active infection with human immunodeficiency virus (HIV), hepatitis B virus, or hepatitis C virus (HCV)
Uncontrolled underlying disease such as moderate or severe infections and hemorrhage
Severe Heart failure (NYHA class III/IV), congestive heart failure or arrhythmia requiring treatment
History of allogenic hematopoietic stem cell more than once
Positive reaction of a Penicillin test at screening
History of relapse of causative diseases (ALL, CML, CLL, AML, NHL, multiple myeloma e.t.c.) with hematopoietic stem cell transplantation or diagnosed with secondary malignant diseases after hematopoietic stem cell transplantation
History of Anti-thymocyte globulin(ATG) for 2 weeks before Screening visit
History of pulmonary embolism or deep venous thrombosis for 24 weeks before Screening visit